Split History
ETFs Holding CLSN »    CLSN Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Celsion is a development stage oncology drug company focused on developing a portfolio of cancer treatments, including directed chemotherapies, deoxyribonucleic acid (DNA)-mediated immunotherapy and ribonucleic acid based therapies. Co.'s main product candidate is ThermoDox®, a proprietary heat-activated liposomal encapsulation of doxorubicin, in a clinical trial for the treatment of primary liver cancer. Second in Co.'s pipeline is GEN-1, a DNA-mediated immunotherapy for the localized treatment of ovarian and brain cancers. These investigational products are based on two platform technologies including: Lysolipid Thermally Sensitive Liposomes and TheraPlas. According to our CLSN split history records, Celsion has had 2 splits.
CLSN split history picture
Celsion (CLSN) has 2 splits in our CLSN split history database. The first split for CLSN took place on October 29, 2013. This was a 222 for 1000 reverse split, meaning for each 1000 shares of CLSN owned pre-split, the shareholder now owned 222 shares. For example, a 1000 share position pre-split, became a 222 share position following the split. CLSN's second split took place on May 30, 2017. This was a 1 for 14 reverse split, meaning for each 14 shares of CLSN owned pre-split, the shareholder now owned 1 share. For example, a 222 share position pre-split, became a 15.8571428571429 share position following the split.

When a company such as Celsion conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the CLSN split history from start to finish, an original position size of 1000 shares would have turned into 15.8571428571429 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Celsion shares, starting with a $10,000 purchase of CLSN, presented on a split-history-adjusted basis factoring in the complete CLSN split history. CLSN split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/12/2011
End date: 05/11/2021
Start price/share: $174.02
End price/share: $1.05
Dividends collected/share: $0.00
Total return: -99.40%
Average Annual Total Return: -40.00%
Starting investment: $10,000.00
Ending investment: $60.30
Years: 10.01
Date Ratio
10/29/2013222 for 1000
05/30/20171 for 14
CLSN is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

CMD Split History
CMN Split History
CNC Split History
CNDO Split History
CNMD Split History
COO Split History
COV Split History
CRDC Split History
CRIS Split History
CRMD Split History

Also explore: CLSN shares outstanding history

LM Funding America, Inc. (LMFA)
Foxby Corp. (XFXBX)
InspireMD, Inc. (NSPR)
Aviat Networks, Inc. (AVNW)
Guardion Health Sciences, Inc. (GHSI)
China SXT Pharmaceuticals, Inc. (SXTC)
VYNE Therapeutics Inc. (VYNE)
The Sherwin-Williams Company (SHW)
Horizons US Marijuana Index ETF (HMUS)
MicroSectors FANG+ ETNs due January 8, 2038 (FNGS)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

CLSN Insider Buying

CLSN Split History | www.SplitHistory.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.